Julian Farrugia

A hostile takeover, a rival suitor, and a German facility expansion: why the Aurora-Curaleaf saga matters beyond North America.

Europe's oldest medicinal cannabis producer has gone bankrupt — and the Dutch government's refusal to accept delivered stock may have sealed its fate.

With global hemp production continuing to outpace demand, researchers and regulators are asking whether animal feed could become a genuine secondary market.

A June 2026 German regulatory ruling has quietly redrawn the rules for cannabis imports — and most Asia-Pacific producers haven't caught up.

The Jersey cultivator's turnaround from liquidation risk to operational profitability offers a rare template for European cannabis operators navigating the sector's brutal economics.

The pharmaceutical potential of cannabis may be far greater than current medicine reflects — and the bottleneck is not science, but supply and education.

French trade groups challenge an abrupt market ban on CBD food products, with implications that reach well beyond France's borders.

A Swedish researcher's patent application could reshape how clinicians and patients understand cannabis tolerance and ECS function.